Creatine for Midlife Men: Muscle, Strength and Fat Loss

On August 21, 2026, the Journal of the International Society of Sports Nutrition published a trial on whether creatine monohydrate affects body composition and strength. The study evaluated these physical markers in healthy adults aged 45 to 65 over a 12-week period.
Trial Details
The researchers registered the intervention under ISRCTN83081058 and initially evaluated 136 individuals. Seventy-three healthy and untrained adults were randomized for the testing period. Sixty-four participants completed the full clinical protocol. This final group had an average age of 54.5 years.
The cohort included 24 men and 40 women. The participants first decided whether they would enter a supervised exercise and diet program or remain sedentary. The researchers then randomly assigned the participants to receive either creatine or a placebo.
The active supplement groups consumed 10 grams of creatine monohydrate daily. The researchers divided this amount into two equal servings. The placebo group received maltodextrin supplied in visually identical sachets.
The structured training program required three supervised exercise sessions each week. These workouts combined full-body resistance training with roughly 20 minutes of aerobic activity. The resistance exercises utilized three sets of 10 repetitions for each movement. Trainers progressively increased the external loads at intervals of one to two weeks to force physical adaptation.
Participants in the exercise program followed specific daily activity targets. They were instructed to accumulate 10,000 steps on four non-training days each week. The researchers provided an individualized diet designed to create an energy deficit of 300 to 500 calories per day. This nutritional protocol targeted 55 percent carbohydrate, 15 percent protein and 30 percent fat.
The average reported protein intake during the trial was 74.3 grams per day. This equates to 0.94 grams of protein per kilogram of body weight. The trial tested supplementation within a modest protein intake rather than a specialized muscle-building diet. For middle-aged men returning to physical activity, this nutritional context highlights that functional improvements are possible without extreme dietary overhauls.
Measured Outcomes
Muscle and Body Composition
The non-exercise group taking the supplement gained approximately 1.1 kilograms of lean tissue over the trial. The non-exercise placebo group recorded a small decline in lean tissue during the same timeframe. The participants combining structured exercise with the supplement gained roughly 1.27 kilograms of lean tissue. The group following the same concurrent training program with a placebo gained about 0.14 kilograms.
Body fat reductions followed a clear pattern during the 12-week intervention. The active exercise group taking the supplement reduced their body-fat percentage by approximately 3.24 percentage points. The exercise group receiving the placebo achieved a reduction of approximately 1.87 percentage points. The researchers reported this specific difference in body fat reduction as statistically significant.
A separate meta-analysis previously found no significant fat mass improvements from supplementation during resistance training. The new trial showed greater fat reduction when the compound was combined with supervised exercise and caloric restriction. Men aiming for body recomposition should note that the supplement did not cause fat loss by itself. The combination of structured movement and targeted nutrition remains the most reliable method for improving body composition.
Strength Adaptations
The participants taking the supplement without structured exercise improved their muscular endurance. They also increased their one-repetition maximum on both the bench press and the leg press. Combining the supplement with the supervised exercise program produced far greater strength improvements. The active training group achieved substantial increases in time to exhaustion and maximal strength.
The most prominent physical adaptations occurred in the leg-press one-repetition maximum. This specific lift recorded a group-by-time effect of p = 0.001. The bench-press one-repetition maximum yielded a group-by-time effect of p = 0.003. As men age past 45, maintaining functional lower body strength becomes critical for daily independence.
These strength findings align with existing historical data on physical adaptation in older populations. A separate meta-analysis of older adult resistance-training studies reported a mean difference of 1.37 kilograms in lean tissue mass for the active supplement compared to placebo. That analysis also noted broad improvements in chest-press and leg-press strength. Those metrics confirm the utility of specific interventions for preserving strength and power after 45.
Health and Cognitive Markers
The trial tracked several preliminary health variables and cognitive markers over the 12 weeks. The exercise group taking the active supplement scored higher on the MMSE cognitive test than the non-exercise groups. Some MAC-Q memory items also favored the supplemented participants. Delayed word recall showed a significant time effect, but the overall word-recall interaction lacked statistical significance.
The study did not record statistically significant improvements in aerobic capacity. HbA1c levels decreased in both exercise groups and the non-exercise active supplement group. Fasting glucose did not change during the trial. The researchers noted favorable changes in selected lipid measures for the non-exercise active group.
The study reported no significant group or time effects for bone mineral content, bone area or bone mineral density.
Trial Limitations
Exploratory Findings
The researchers explicitly classified the individual cognitive tasks and biomarker outcomes as exploratory. These specific endpoints were not separately powered as confirmatory results. Several specific cognitive tests failed to show clear improvements related to the supplement. The null results included picture recognition, digit vigilance, Stroop performance, Corsi block performance and NeuroTracker measures.
The authors noted that the overall lipid panel lacked a significant multivariate group-by-time interaction. They found no consistent pattern across the various lipid outcomes. Readers should remain cautious about claims linking brain health after 45 to single dietary interventions based on early signals.
The small sample size limits the broad application of these secondary findings. The final groups ranged from just 13 to 20 participants. This low volume increases uncertainty regarding the reliability of the preliminary cognitive and metabolic findings. The exercise participation was entirely self-selected rather than randomized.
The individuals who chose the supervised exercise program may have possessed different baseline fitness levels or health behaviors. This structural limitation means the exercise groups might not perfectly represent the general older adult population.
Kidney and Long-Term Context
Serum creatinine increased in the active supplement groups by less than 0.15 mg/dL. The creatinine-based estimated glomerular filtration rate declined during the trial. These values remained within clinically normal ranges for the duration of the study. The authors cautioned that creatinine-based filtration estimates can be influenced by active supplementation and increased muscle mass.
The researchers did not directly measure glomerular filtration rate or cystatin C. The trial reported similar and minimal side effects across all groups. No participant withdrew from the study for supplement-related problems. Anyone with existing kidney conditions should discuss supplementation with a primary care physician before beginning a new protocol.
The 12-week timeframe cannot establish whether these physical changes persist indefinitely. One distinct 12-month study in older men found that this supplement did not improve the adaptations produced by supervised resistance training alone. The specific 10-gram daily dose in this trial was selected partly to target brain levels. This dosage should not be viewed as universally necessary for basic physical preservation.
The broader position-stand evidence from the International Society of Sports Nutrition offers reassurance on basic use. They describe the compound as safe and well tolerated at doses up to 30 grams per day for up to five years across tested populations.
What Changes
What this changes: This research confirms that active supplementation acts as a practical physical support during caloric restriction, but it does not establish the compound as a reliable treatment for cognitive decline or a replacement for progressive resistance training.
How Everfitguys helps
Expecting a dietary supplement to reverse physical decline without structured exercise leaves many older adults vulnerable to exaggerated fitness claims. Not knowing which longevity and healthy aging claims are actually supported by research complicates decisions about muscle retention, and Everfitguys translates clinical trial data to help you build functional capacity using proven methods.
Sources
Stay sharp
Get stories
The best writing on craft and life, delivered once a week. No noise, just the good stuff.



